Cargando…
Identification of TPD52 and DNAJB1 as two novel bile biomarkers for cholangiocarcinoma by iTRAQ-based quantitative proteomics analysis
Cholangiocarcinoma (CCA) represents a type of epithelial cancer with a late diagnosis and poor outcome. However, the molecular mechanisms responsible for the development of CCA have not yet been fully identified. Thus, in this study, we aimed to elucidate some of these mechanisms. For this purpose,...
Autores principales: | Ren, Hongyue, Luo, Mingxu, Chen, Jinzhong, Zhou, Yanming, Li, Xiumei, Zhan, Yanyan, Shen, Dongyan, Chen, Bo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6859461/ https://www.ncbi.nlm.nih.gov/pubmed/31661142 http://dx.doi.org/10.3892/or.2019.7387 |
Ejemplares similares
-
i-Tracker: For quantitative proteomics using iTRAQ™
por: Shadforth, Ian P, et al.
Publicado: (2005) -
iTRAQ-based proteomics reveals novel biomarkers of osteoarthritis
por: Ikeda, Daiki, et al.
Publicado: (2013) -
Proteomic analysis by iTRAQ-MRM of soybean resistance to Lamprosema Indicate
por: Zeng, Weiying, et al.
Publicado: (2017) -
Serum proteomics analysis and comparisons using iTRAQ in the progression of hepatitis B
por: PENG, LIANG, et al.
Publicado: (2013) -
iTRAQ-based quantitative proteomic analysis of salt stress in Spica Prunellae
por: Liu, Zixiu, et al.
Publicado: (2019)